<PAGE>
OMB APPROVAL
-------------------------
OMB NUMBER: 3235-0145
EXPIRES: AUGUST 31, 1999
ESTIMATED AVERAGE BURDEN
HOURS PER RESPONSE....14.90
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
Shaman Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
819319 10 4
(Cusip Number)
(Date of Event Which Requires Filing of this Statement: April 12. 1999)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement /X/. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP No. 819319 10 4 13D Page 2 of 6 Pages
================================================================================
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Vincent Crisci
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED [_]
PURSUANT TO ITEMS 2(d) OR 2(e)
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
2,005,000
SHARES -------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY -------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
2,005,000
REPORTING -------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,005,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [_]
EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
CUSIP No. 819319 10 4 13D Page 3 of 6 Pages
================================================================================
ITEM 1(a). NAME OF ISSUER:
Shaman Pharmaceuticals, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
213 East Grand Avenue, South San Francisco, California 94080
ITEM 2(a). NAME OF PERSON FILING:
Vincent Crisci
None of the above referenced filer/s has, during the past five years, been
convicted in a criminal proceeding, excluding traffic violations or similar
misdemeanors, nor have any of the Holders been a party to a civil proceeding of
a judicial or administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree, or final order
enjoining future violations of, or prohibiting or mandating activity subject to
federal or state securities laws or finding any violation with respect to such
laws.
ITEM 2(b). ADDRESS OF PRINCIPAL OFFICE OR, IF NONE, RESIDENCE:
8 East 12 Street, New York, N. Y. 10003
ITEM 2(c). CITIZENSHIP:
Vincent Crisci is a citizen of the United States.
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $0.001
ITEM 2(e). CUSIP NUMBER: 819319 10 4
ITEM 3. SOURCE OF FUNDS.
PF
ITEM 4. OWNERSHIP.
(a) Amount beneficially owned: 2,005,000
(b) Percent of class:
6.0% (based on the 33,277,402 shares of Common Stock
(the "Common Stock") of Shaman Pharmaceuticals, Inc. (the "Company"), including
those reported to be outstanding as of December 31, 1998, as reflected in the
Company'squarterly report on Form 10-K filed with the Securities and Exchange
Commission by the Company.
<PAGE>
CUSIP No. 819319 10 4 13D Page 4 of 6 Pages
===============================================================================
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
2,005,000
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the
disposition of: 2,005,000
(iv) shared power to dispose or to direct the
disposition of: 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
Transactions by the Holders in the securities of Shaman in the last 60
days are as follows:
<TABLE>
<CAPTION>
DATE QUANT DESCRIPTION PRICE
- ---------------------------------------------------------------------
<S> <C> <C> <C>
4/12 500,000 SHAMAN PHARM INC 0.075
4/01 200,000 SHAMAN PHARM INC 0.155
3/26 5,000 SHAMAN PHARM INC 0.1718
3/25 117,200 SHAMAN PHARM INC 0.1718
3/25 100,000 SHAMAN PHARM INC 0.178
3/25 40,800 SHAMAN PHARM INC 0.175
3/25 37,000 SHAMAN PHARM INC 0.17
3/16 169,000 SHAMAN PHARM INC 0.23
3/16 100,000 SHAMAN PHARM INC 0.2031
3/16 25,000 SHAMAN PHARM INC 0.21
3/16 15,000 SHAMAN PHARM INC 0.20
3/16 13,500 SHAMAN PHARM INC 0.2187
3/15 155,000 SHAMAN PHARM INC 3/16
3/15 25,000 SHAMAN PHARM INC 0.185
3/15 2,500 SHAMAN PHARM INC 0.18
3/11 49,500 SHAMAN PHARM INC 0.2031
3/10 100,000 SHAMAN PHARM INC 1/4
3/09 100,000 SHAMAN PHARM INC 1/4
2/22 20,000 SHAMAN PHARM INC 3/8
2/19 3,900 SHAMAN PHARM INC 5/16
</TABLE>
All transactions were effected on the NASDAQ exchange through Filers brokerage
account.
<PAGE>
CUSIP No. 819319 10 4 13D Page 5 of 6
Pages
========================================================================
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION. (if filing pursuant to Rule 13d-1(b))
By signing below Vincent Crisci certify that, to the best of his
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
<PAGE>
CUSIP No. 819319 10 4 13D Page 6 of 6
Pages
========================================================================
SIGNATURE
After reasonable inquiry and to the best of their knowledge
and belief, the undersigned certify that the information set forth in this
statement is true, complete and correct
April 19, 1999
Vincent Crisci
/s/ Vincent Crisci
----------------------------------------
Vincent Crisci
